1,437
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

B-type natriuretic peptide levels and volume status in twice-weekly hemodialysis patients

, , , , , , , & show all
Pages 1259-1265 | Received 24 Feb 2021, Accepted 09 Aug 2021, Published online: 31 Aug 2021

References

  • Kalantar-Zadeh K, Unruh M, Zager PG, et al. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis. 2014;64(2):181–186.
  • Merino JL, Domínguez P, Bueno B, et al. Application of a pattern of incremental haemodialysis, based on residual renal function, when starting renal replacement therapy. Nefrologia. 2017;37(1):39–46.
  • Ghahremani-Ghajar M, Rojas-Bautista V, Lau WL, et al. Incremental hemodialysis: the university of California Irvine experience. Semin Dial. 2017;30(3):262–269.
  • Hemodialysis Adequacy 2006 Work group: clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006;48(Suppl 1):S2–S90.
  • Obi Y, Streja E, Rhee CM, et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis. 2016;68(2):256–265.
  • Panaput T, Thinkhamrop B, Domrongkitchaiporn S, et al. Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study. Blood Purif. 2014;38(3–4):253–262.
  • Lin X, Gu L, Zhu M, et al. Clinical outcome of twice-weekly hemodialysis patients with long-term dialysis vintage. Kidney Blood Press Res. 2018;43(4):1104–1112.
  • Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. JASN. 2002;13(5):1307–1320.
  • Shu Y, Liu J, Zeng X, et al. The effect of overhydration on mortality and technique failure among peritoneal dialysis patients: a systematic review and meta-analysis. Blood Purif. 2018;46(4):350–358.
  • Moissl UM, Wabel P, Chamney PW, et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas. 2006; 27(9):921–933.
  • Chamney PW, Wabel P, Moissl UM, et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007;85(1):80–89.
  • Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009;24(5):1574–1579.
  • Stenberg J, Melin J, Lindberg M, et al. Brain natriuretic peptide reflects individual variation in hydration status in hemodialysis patients. Hemodial Int. 2019;23(3):402–413.
  • Booth J, Pinney J, Davenport A. N-terminal proBNP-marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol. 2010;5(6):1036–1040.
  • Lee SW, Song JH, Kim GA, et al. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis. 2003;41(6):1257–1266.
  • Tapolyai M, Faludi M, Réti V, et al. Volume estimation in dialysis patients: the concordance of brain-type natriuretic peptide measurements and bioimpedance values. Hemodial Int. 2013;17(3):406–412.
  • Jule P, Charles C, Stefano S, et al. Sodium, volume and pressure control in haemodialysis patients for improved cardiovascular outcomes. Nephrol Dial Transplant. 2020;35(Suppl 2):ii23–ii30.
  • Devolder I, Verleysen A, Vijt D, et al. Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int. 2010;30(2):208–214.
  • Hassan MO, Duarte R, Dix-Peek T, et al. Volume overload and its risk factors in South African chronic kidney disease patients: an appraisal of bioimpedance spectroscopy and inferior vena cava measurements. CN. 2016;86(07):27–34.
  • Han BG, Lee JY, Kim MR, et al. Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysis. PLOS One. 2020;15(7):e0235640.
  • Yasushi O, Akinobu S, Keisuke Y, et al. Brain natriuretic peptide and body fluid composition in patients with chronic kidney disease: a cross-sectional study to evaluate the relationship between volume overload and malnutrition. Cardiorenal Med. 2016;6(4):337–346.
  • Hassan MO, Duarte R, Dix-Peek T, et al. Correlation between volume overload, chronic inflammation, and left ventricular dysfunction in chronic kidney disease patients. CN. 2016;86(S1):131–135.
  • Carlos C, Grimes B, Segal M, et al. Predialysis fluid overload and gait speed: a repeated measures analysis among patients on chronic dialysis. Nephrol Dial Transplant. 2020;35(6):1027–1031.
  • Hung SC, Lai YS, Kuo KL, et al. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J Am Heart Assoc. 2015;4(5):e001918.
  • Faucon AL, Flamant M, Metzger M, et al. Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease. Kidney Int. 2019;96(4):1020–1029.
  • Couchoud C, Kooman J, Finne P, et al. Quality european studies working group on dialysis adequacy: from registry data collection to international comparisons: examples of haemodialysis duration and frequency. Nephrol Dial Transplant. 2008;24(1):217–224.
  • Zhang M, Wang M, Li H, et al. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol. 2014;40(2):140–150.
  • Lin X, Yan Y, Ni Z, et al. Clinical outcome of twice-weekly hemodialysis patients in Shanghai. Blood Purif. 2012;33(1–3):66–72.